Attributed PubMed bibliography

Carfilzomib literature

25 selected PubMed bibliographic records connected to the reviewed Carfilzomib identity. Identity matching connects these records; it does not summarize their findings or imply safety, effectiveness, or scientific agreement.

Bibliographic records

25 selected records.

Publication years

6 attributed years.

Attributed venues

17 distinct venues.

Publication chronology

Selected records

All literature facets →

The Lancet. Oncology · 2021 11 11

Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial.

Clinical Trial, Phase II · Journal Article · Multicenter Study · Randomized Controlled Trial · Research Support, Non-U.S. Gov't

Open attributed record →